New Delhi, May 21: US pharmaceutical giant Gilead Sciences is likely to apply to India's Central Drugs Standard Control Organisation (CDSCO) soon seeking marketing authorisation for its anti-viral drug remdesivir, which is being considered by many as a potential medication for
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/2ZryNfY
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/2ZryNfY
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
Related Post
Joshimath: NDRF on standby to assist local administration, says officialThe team of the National Disaster Response Force (NDRF) rescuers have reached the location from the- Karnataka election 2023: Which way will the Lingayat vote swing? Find out in this surveyAhead of the Karnataka Assembly elections, a survey conducted in the poll bound state showed the tw
- No Karnataka tableau on Republic Day parade this year: GovtCongress leader Siddaramaiah has targeted the State BJP government in this regard, by questioning i
- If Sanjay Raut is saying...: Sharad Pawar on NCP CMNationalist Congress Party President Sharad Pawar on Wednesday reacted to Rajya Sabha MP Sanjay Rau
ConversionConversion EmoticonEmoticon